Effect of resveratrol and zinc on intracellular zinc status in normal human prostate epithelial cells

American Journal of Physiology - Cell Physiology

Volumn 297, Issue 3, 2009, Pages

  Zhang, Jun Jun ^a   Wu, Min ^a   Schoene, Norberta W ^b   Cheng, Wen Hsing ^a   Wang, Thomas T Y ^b   Alshatwi, Ali A ^c   Alsaif, Mohammed ^c   Lei, Kai Y ^a,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Nutrient interaction; Zinquin

Indexed keywords

REACTIVE OXYGEN METABOLITE; RESVERATROL; ZINC;

ADULT; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE EPITHELIUM; SENESCENCE; SPECTROFLUOROMETRY;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; MALE; PROSTATE; STILBENES; YOUNG ADULT; ZINC;

EID: 70349295862     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00139.2009     Document Type: Article

References (44)

1. Ahmad A, Farhan AS, Singh S, Hadi SM. DNA breakage by resveratrol and Cu(II): reaction mechanism and bacteriophage inactivation. Cancer Lett 154: 29-37, 2000. (Pubitemid 30229906)
2. Aydemir TB, Blanchard RK, Cousins RJ. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc Natl Acad Sci USA 103: 1699-1704, 2006.
3. Azmi AS, Bhat SH, Hadi SM. Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett 579: 3131-3135, 2005.
4. Azmi AS, Bhat SH, Hanif S, Hadi SM. Plant polyphenols mobilize endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for anticancer properties. FEBS Lett 580: 533-538, 2006. (Pubitemid 43089682)
5. Belguendouz L, Fremont L, Linard A. Resveratrol inhibits metal ion-dependent and -independent peroxidation of porcine low-density lipoproteins. Biochem Pharmacol 53: 1347-1355, 1997. (Pubitemid 27305634)
6. Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA, Brenner DE, Booth TD, Gescher A, Steward WP. Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J Chromatogr B Biomed Appl 848: 182-187, 2007. (Pubitemid 46464044)
7. 2+ ions: implications for their antioxidant properties. Biochem J 330: 1173-1178, 1998.
8. Burkitt MJ, Duncan J. Effects of trans-resveratrol on copper-dependent hydroxyl radical formation and DNA damage: evidence for hydroxyl radical scavenging and a novel glutathione-sparing mechanism of action. Arch Biochem Biophys 381: 253-263, 2000.
9. Cao Y, Fu ZD, Wang F, Liu HY, Han R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J Asian Nat Prod Res 7: 205-213, 2005. (Pubitemid 40139352)
10. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998. (Pubitemid 28355484)
11. Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 7: 111-117, 2004. (Pubitemid 38931432)
12. Cousins RJ, Blanchard RK, Popp MP, Liu L, Cao J, Moore JB, Green CL. A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Natl Acad Sci USA 100: 6952-6957, 2003. (Pubitemid 36706374)
13. Coyle P, Zalewski PD, Philcox JC, Forbes IJ, Ward AD, Lincoln SF, Mahadevan I, Rofe AM. Measurement of zinc in hepatocytes by using a fluorescent probe, zinquin: relationship to metallothionein and intracellular zinc. Biochem J 303: 781-786, 1994. (Pubitemid 24326011)
14. Delmas D, Passilly-Degrace P, Jannin B, Cherkaoui MM, Latruffe N. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med 10: 193-199, 2002.
15. Eide DJ. Zinc transporters and the cellular trafficking of zinc. Biochim Biophys Acta 1763: 711-722, 2006.
16. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 341: 1103-1104, 1993.
17. Fukuhara K, Miyata N. Resveratrol as a new type of DNA-cleaving agent. Bioorg Med Chem Lett 8: 3187-3192, 1998. (Pubitemid 28551644)
18. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94: 14138-14143, 1997.
19. Gescher AJ, Steward WP. Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12: 953-957, 2003.
20. Hambidge KM, Casey CE, Krebs NF. Zinc. In: Trace Elements in Human and Animal Nutrition, edited by W. Mertz. New York: Academic, 1986, p. 1-137.
21. Hammerschmidt R. Phytoalexins: What have we learned after 60 years? Annu Rev Phytopathol 37: 285-306, 1999. (Pubitemid 29523937)
22. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, Arany P, Green JE. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67: 8396-8405, 2007. (Pubitemid 47395179)
23. Iwahashi H, Ishii T, Sugata R, Kido R. The effects of caffeic acid and its related catechols on hydroxyl radical formation by 3-hydroxyanthranilic acid, ferric chloride, and hydrogen peroxide. Arch Biochem Biophys 276: 242-247, 1990. (Pubitemid 20041840)
24. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997. (Pubitemid 127696281)
25. Kavas GO, Ribal-Kocaturk P, Buyukkagnici DI. Resveratrol: is there any effect on healthy subject? Biol Trace Elem Res 118: 250-254, 2007.
26. Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 53: 6-15, 2006. (Pubitemid 41619373)
27. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302: 369-373, 2002. (Pubitemid 34680460)
28. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360: 142-148, 1998.
29. Orallo F. Comparative studies of the antioxidant effects of cis- and trans-resveratrol. Curr Med Chem 13: 87-98, 2006.
30. Prasad AS. Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nutr Rev 41: 197-208, 1983.
31. Reaves SK, Fanzo JC, Arima K, Wu JY, Wang YR, Lei KY. Expression of the p53 tumor suppressor gene is up-regulated by depletion of intracellular zinc in HepG2 cells. J Nutr 130: 1688-1694, 2000. (Pubitemid 30451054)
32. Renaud S, de Longeril M. The French paradox: dietary factors and cigarette smoking-related health risks. Ann NY Acad Sci 686: 299-309, 1993. (Pubitemid 23204435)
33. Min+ mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J Cancer 115: 194-201, 2005.
34. Smith PJ, Wiltshire M, Furon E, Beattie JH, Errington RJ. Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity. Am J Physiol Cell Physiol 295: C1399-C1408, 2008. (Pubitemid 352790346)
35. Soleas GJ, Goldberg DM, Grass L, Levesque M, Diamandis EP. Do wine polyphenols modulate p53 gene expression in human cancer cell lines? Clin Biochem 34: 415-420, 2001. (Pubitemid 32777852)
36. Suzuki T, Umeyama T, Ohma C, Yamanaka H, Suzuki K, Nakajima K, Kimura M. Immunohistochemical study of metallothionein in normal and benign prostatic hyperplasia of human prostate. Prostate 19: 35-42, 1991.
37. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals 14: 315-330, 2001. (Pubitemid 34066635)
38. Truong-Tran AQ, Ruffin RE, Zalewski PD. Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines. Am J Physiol Lung Cell Mol Physiol 279: L1172-L1183, 2000.
39. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK, Lin PY, Chen Y. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202, 2004. (Pubitemid 38375581)
40. Uenobe F, Nakamura S, Miyazawa M. Antimutagenic effect of resveratrol against Trp-P-1. Mutat Res 373: 197-200, 1997. (Pubitemid 27478863)
41. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev 73: 79-118, 1993.
42. Wallwork JC, Sandstead HH. Zinc and brain function. Prog Clin Biol Res 380: 65-80, 1993.
43. Wong SH, Zhao Y, Schoene NW, Han CT, Shih RS, Lei KY. Zinc deficiency depresses p21 gene expression: inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells. Am J Physiol Cell Physiol 292: C2175-C2184, 2007. (Pubitemid 47080535)
44. Zalewski PD, Forbes IJ, Betts WH. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6- quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem J 296: 403-408, 1993.